# FlowLens Industrial AI — W03-C10 Business Acceptance Readiness Dossier

> Task: W03-C10-I/H/R; contract: W03-C10-A-v1; date: 2026-10-05 (Asia/Shanghai).
> Codex prepares technical evidence only. All Product Owner assessment and notes
> remain PENDING_PRODUCT_OWNER_DECISION. BUSINESS ACCEPTANCE: PENDING.

## 1. Evidence baseline

**OBSERVED:** Read-only preflight passed before mutation. Branch
`feat/w03-ai-decision-loop`; local/tracking/direct-remote/PR #6 source head
`147cefae890d3a450052298f0a331e1528e1f856`; main
`9d18ddde9fe933952a2661ee1419f13c8577605d`; clean tree/staging; ahead/behind 0/0;
PR OPEN / DRAFT / NOT MERGED; auto-merge absent/disabled. Run #80 /
`37220934558` succeeded: P / PUBLICATION_EXACT_SHA, Publication proof and
Verification PASS, Quality/Compose/W03 SKIPPED.

The active Product Owner request supplied `W03-C10 HUMAN AUTHORIZATION: APPROVED`.
All 19 package checksums passed. ZIP SHA-256:
`7c952fae08dd1d7a776495000b0f10d49d83fd874a90be33507565b920f8b8be`.
The published `W03_C10_CONTEXT_LOCK.md` is LOCKED before this dossier/sprint write;
its Section 3 records all 20 verified protected entry identities.

Accepted repository evidence chain:

| Evidence | Exact identity / proof | Repository anchor |
|---|---|---|
| C09 implementation, inherited C01-C08 proofs | `f214b20e54e2ff6ad3c1227ebb53e4aadaa204c9`; Run #78 / 37216528805; I / FULL_EXACT_SHA; Quality, Compose, W03 and Verification PASS | `docs/w03/reports/W03_C09_R_DEVELOPMENT_ROUND_REPORT.md`, Sections 12-18 |
| Frozen semantic gate | F01-F10; 38 exact selectors; 85 expanded cases PASS | `docs/w03/checkpoints/c09/specs/c09_gate_manifest.json` |
| C09 post-CI audit | H01-H42, 42/42 PASS | C09 development report, Section 12 |
| C09 report publication | `330241be4039711e32d631a6d83eb36edd1f2888`; Run #79 / 37218374366; P / PUBLICATION_EXACT_SHA PASS | `docs/w03/reports/W03_C09_GPT_INDEPENDENT_REVIEW_R1.md`, Section 3 |
| C09 independent review and Human acceptance | GPT R1 PASS FOR HUMAN C09 ACCEPTANCE; actual Human acceptance and closeout authorization recorded | `docs/w03/reports/W03_C09_C1_FINAL_CLOSEOUT.md`, Sections 1, 2, 7 |
| Effective C09 closeout | Entry SHA; Run #80 / 37220934558 PASS and observed entry synchronization | C09 closeout, Sections 4-6; C10 Context Lock observed-entry record |

The C10 implementation SHA and CI do not exist when this immutable implementation
document is authored. The separate post-CI
`docs/w03/reports/W03_C10_R_BUSINESS_ACCEPTANCE_READINESS_REPORT.md` will bind this
dossier to the actual C10 commit, FULL proof and H01-H34 audit. No future SHA/run is
invented, and inherited Run #78 is not substituted for C10 exact-SHA proof.

Each dimension below uses the accepted chain above. References outside the 38
critical selectors are accepted upstream/full Quality-suite evidence; the family
references identify the frozen critical regression coverage.

## 2. W3 end-to-end path

```text
Operational Facts
→ Decision-Time Snapshot
→ Semantic Trust / Evidence
→ Signals
→ Diagnosis
→ Authorized Candidates
→ Counterfactual Simulation
→ Candidate Evaluation
→ RecommendationRecord
→ DecisionPacket
→ Bounded Explanation
→ HumanDecisionEvent
→ Offline Evaluation / Replay
```

**DERIVED:** This is the accepted architecture/evidence chain in W03 Sprint
Sections 3 and 7-15 and `LOOP.md`, with protected evaluation separated from
runtime. C10 assembles the review surface; it adds no orchestration runtime.

Mode remains OFFLINE / SHADOW / HUMAN-IN-THE-LOOP / NO OPERATIONAL MUTATION.

## 3. A01-A10 acceptance matrix

### A01 STATE_INTERPRETABILITY

Review question: Can the Product Owner understand the decision-time order state,
time boundary, trust labels, provenance, limitations and unresolved state without
hidden inference?

Technical status: EVIDENCE_READY.

Accepted evidence and concrete anchors:
`docs/w03/checkpoints/c01/W03_C01_CORE_ARTIFACT_CONTRACTS.md`;
`docs/w03/checkpoints/c02/W03_C02_SOURCE_FIELD_SNAPSHOT_MATRIX.md`;
`tests/test_decision_snapshot.py::test_snapshot_replay_and_source_exclusion`;
`tests/test_decision_evidence.py::test_association_derivation_and_quality_unknowns`;
`tests/test_decision_context.py::test_three_critical_conflicts_are_preserved`.
Critical regression: F01 CORE_CONTRACTS and F02 TEMPORAL_SEMANTIC_TRUST.

What evidence proves: immutable StateSnapshot binds order/time/dataset identity;
EvidenceBundle and DecisionContext retain source references, availability, trust,
limitations, UNKNOWN and unresolved critical conflicts. Future/latest status is
excluded where it has no valid historical event basis.

What evidence does NOT prove: complete real-factory state, a bitemporal W2 history,
formal post-rework quality release, or Product Owner comprehension.

Known limitations: W2 non-bitemporal status exclusion, synthetic freshness policy,
missing release event, and associative procurement must remain visible.

Product Owner assessment: PENDING_PRODUCT_OWNER_DECISION.
Product Owner notes: PENDING_PRODUCT_OWNER_DECISION.

### A02 RISK_USEFULNESS

Review question: Do the frozen risk signals and structured diagnosis help a
Production / Delivery Operations Manager identify where investigation should begin
without claiming unsupported root cause?

Technical status: EVIDENCE_READY.

Accepted evidence and concrete anchors:
`docs/w03/checkpoints/c03/W03_C03_SIGNAL_RULEBOOK.md`;
`docs/w03/checkpoints/c03/W03_C03_DIAGNOSIS_CONTRACT.md`;
`tests/test_c03_signals.py::test_published_golden_signal_vectors`;
`tests/test_c03_diagnosis.py::test_diagnosis_is_fixed_template_structured_and_noncausal`;
`tests/test_c03_harness.py::test_all_critical_conflicts_fail_closed`.
Critical regression: F03 SIGNAL_DIAGNOSIS_FAIL_CLOSED; dataset direction coverage F09.

What evidence proves: deterministic Supplier/Material/Quality/Rework/Queue/Capacity/
Delivery signal vocabulary and structured claims preserve signal evidence IDs,
limitations and uncertainty; critical conflicts block trust. Diagnosis is a
bounded investigation surface.

What evidence does NOT prove: causal/root-cause truth, calibrated prediction,
risk reduction, or business usefulness to a particular manager.

Known limitations: CAPACITY_PRESSURE remains UNKNOWN where utilization evidence
does not exist; associative material/supplier evidence cannot establish allocation.

Product Owner assessment: PENDING_PRODUCT_OWNER_DECISION.
Product Owner notes: PENDING_PRODUCT_OWNER_DECISION.

### A03 EVIDENCE_USEFULNESS

Review question: Is decision-relevant evidence traceable, bounded by time/trust/
provenance, and useful for human investigation while associative evidence remains
visibly associative?

Technical status: EVIDENCE_READY.

Accepted evidence and concrete anchors:
`docs/w03/SEMANTIC_TRUST_CONTRACT.md`, Sections 2-5;
`docs/w03/checkpoints/c02/W03_C02_EVIDENCE_TRUST_FRESHNESS_MATRIX.md`;
`tests/test_decision_evidence.py::test_source_evidence_is_exactly_snapshot_backed`;
`tests/test_decision_evidence.py::test_association_derivation_and_quality_unknowns`;
`tests/test_decision_context.py::test_context_is_lossless_partitioned_and_replayable`.
Critical regression: F02 and F03.

What evidence proves: source entity/record/field/value, observed_at/available_at,
relationship, trust, freshness, limitations and provenance remain inspectable.
Context retains evidence partitions and diagnosis claims retain supporting IDs.

What evidence does NOT prove: the external truth of synthetic facts, order-specific
PO allocation, causal truth, or the business value of an investigation.

Known limitations: PO material/time proximity is ASSOCIATIVE_EVIDENCE;
inventory freshness does not establish current available-to-promise stock.

Product Owner assessment: PENDING_PRODUCT_OWNER_DECISION.
Product Owner notes: PENDING_PRODUCT_OWNER_DECISION.

### A04 HONESTY_OF_UNCERTAINTY

Review question: Are UNKNOWN, conflict, insufficiency, abstention and degraded
explanation states visible rather than silently resolved or converted into confidence?

Technical status: EVIDENCE_READY.

Accepted evidence and concrete anchors:
`tests/test_decision_context.py::test_three_critical_conflicts_are_preserved`;
`tests/test_c05_policy.py::test_delivery_unknown_and_all_active_unavailable_abstain`;
`tests/test_c05_policy.py::test_strict_neutral_blocker_matrix_is_fail_closed`;
`tests/test_c08_explanation.py::test_second_schema_failure_degrades_after_exactly_two_calls`;
`docs/w03/FAILURE_AND_DEGRADATION_POLICY.md`.
Critical regression: F02, F05 RECOMMENDATION_ABSTENTION and F08.

What evidence proves: unresolved conflicts remain unresolved; missing/unknown
delivery evidence and unavailable active simulations yield NO_RECOMMENDATION;
partial/tied/nonmonotonic comparisons defer; failed explanations visibly degrade
while the frozen recommendation remains unchanged.

What evidence does NOT prove: statistical confidence, a safe guessed default,
quality release, or that a particular abstention is acceptable to the Product Owner.

Known limitations: UNKNOWN is intentional, not zero; degraded templates reduce
wording freedom and do not repair missing business evidence.

Product Owner assessment: PENDING_PRODUCT_OWNER_DECISION.
Product Owner notes: PENDING_PRODUCT_OWNER_DECISION.

### A05 INTERVENTION_USEFULNESS

Review question: Are the authorized intervention families useful as bounded
investigation options while remaining registry-constrained and non-executing?

Technical status: EVIDENCE_READY.

Accepted evidence and concrete anchors:
`docs/w03/checkpoints/c04/W03_C04_REGISTRY_AND_MAPPING_CONTRACT.md`;
`docs/w03/checkpoints/c04/specs/registry_policy.json`;
`tests/test_c04_registry.py`;
`tests/test_c04_harness.py::test_hgt_free_runtime_adapter_import_and_execution_in_fresh_process`;
`tests/test_c05_harness.py::test_runtime_capability_traps_and_input_immutability`.
Critical regression: F04 COUNTERFACTUAL_ISOLATION and F05.

What evidence proves: exactly four registry families, NO_ACTION,
SUPPLIER_INTERVENTION, QUALITY_INTERVENTION, CAPACITY_INTERVENTION, with frozen
baseline/Supplier Degradation/Quality Deterioration/Capacity Surge mappings;
candidate provenance and relevant signal basis are bounded. No new candidate
authority or execution permission is created.

What evidence does NOT prove: remediation efficacy, procurement feasibility,
resource availability, or authorization to schedule, buy, switch supplier or release quality.

Known limitations: active families are stress probes, with
C04_STRESS_PROBE_NOT_INTERVENTION_EFFICACY and
C04_SCENARIO_SCOPE_NOT_ORDER_TARGETED; relevance is not causality or permission to act.

Product Owner assessment: PENDING_PRODUCT_OWNER_DECISION.
Product Owner notes: PENDING_PRODUCT_OWNER_DECISION.

### A06 COUNTERFACTUAL_CLARITY

Review question: Can the Product Owner clearly distinguish baseline from modeled
counterfactual outcomes, neutral controls and partial/unobservable effects without
reading simulations as operational guarantees?

Technical status: EVIDENCE_READY.

Accepted evidence and concrete anchors:
`docs/w03/checkpoints/c04/W03_C04_SIMULATION_CONTRACT.md`;
`tests/test_c04_simulation.py::test_no_action_is_neutral_stable_and_has_exact_raw_measurement_schema`;
`tests/test_c04_simulation.py::test_baseline_mutation_on_every_error_path_is_a_hard_fail`;
`tests/test_c07_replay.py::test_required_replay_matrix`;
`docs/w03/checkpoints/c07/W03_C07_EVALUATION_POLICY.md`.
Critical regression: F04 and F07 PROTECTED_EVALUATION_REPLAY.

What evidence proves: baseline identity is separate from scenario identity;
NO_ACTION is neutral; supplied baseline bytes are guarded even on error paths.
Protected evaluation distinguishes observable effects, effects not observable
in W3, and neutral control.

What evidence does NOT prove: real-world improvement, an order-targeted intervention,
guaranteed delivery, or a causal treatment effect.

Known limitations: missing baseline makes active simulations UNAVAILABLE;
arrival-only capacity effects may be non-observable, and evaluation returns
non-applicable/null values instead of fabricated correctness.

Product Owner assessment: PENDING_PRODUCT_OWNER_DECISION.
Product Owner notes: PENDING_PRODUCT_OWNER_DECISION.

### A07 RECOMMENDATION_USEFULNESS

Review question: Is the deterministic recommendation or abstention useful for human
review, with candidate basis, modeled comparison, reasons and uncertainty preserved?

Technical status: EVIDENCE_READY.

Accepted evidence and concrete anchors:
`docs/w03/checkpoints/c05/W03_C05_RECOMMENDATION_CONTRACT.md`;
`docs/w03/checkpoints/c05/W03_C05_DECISION_PACKET_CONTRACT.md`;
`docs/w03/checkpoints/c05/specs/evaluation_policy.json`;
`tests/test_c05_policy.py::test_multi_active_matrix_preserves_unique_focus_ties_partial_and_nonmonotonic`;
`tests/test_c05_policy.py::test_delivery_unknown_and_all_active_unavailable_abstain`.
Critical regression: F05.

What evidence proves: fixed categorical stress comparison produces a frozen
RecommendationRecord and DecisionPacket with candidate basis, reason codes,
uncertainties and limitations. A unique worsening stress focus is INVESTIGATION_ONLY;
ties, partial or nonmonotonic active comparisons defer; unsupported paths abstain.

What evidence does NOT prove: optimized production action, calibrated probability,
cost-benefit ranking, or Product Owner acceptance of a recommendation.

Known limitations: C05 v1 dispositions are NO_ACTION, NO_RECOMMENDATION,
INVESTIGATION_ONLY and DEFER_TO_HUMAN. Worsening under a stress probe identifies an
investigation focus; it is not an improving intervention recommendation.

Product Owner assessment: PENDING_PRODUCT_OWNER_DECISION.
Product Owner notes: PENDING_PRODUCT_OWNER_DECISION.

### A08 EXPLANATION_FAITHFULNESS

Review question: Does the bounded explanation faithfully restate the frozen packet
and its limitations without changing recommendation authority, inventing evidence
or resolving uncertainty?

Technical status: EVIDENCE_READY.

Accepted evidence and concrete anchors:
`docs/w03/checkpoints/c08/W03_C08_GROUNDING_FALLBACK_POLICY.md`;
`docs/w03/reports/W03_C08_C1_FINAL_CLOSEOUT.md`, Sections 6-7;
`tests/test_c08_validation.py::test_allowlisted_evidence_id_cannot_ground_unrelated_prose`;
`tests/test_c08_validation.py::test_numeric_token_cannot_be_rebound_to_another_measurement`;
`tests/test_c08_harness.py::test_injection_value_reaches_context_but_cannot_change_behavior`;
`tests/test_c08_harness.py::test_grounding_failure_never_receives_schema_repair`.
Critical regression: F08 LLM_GROUNDING_SCHEMA_INJECTION and F10 RUNTIME_CAPABILITY_ISOLATION.

What evidence proves: exact schema/section order and packet-derived statement
grammar constrain claims; evidence IDs alone cannot ground unrelated prose.
Grounding/injection failures discard the provider output without repair;
schema-only failure allows one repair, at most two calls and SDK retries zero;
deterministic/degraded templates preserve packet/recommendation bytes.

What evidence does NOT prove: arbitrary free-form prose understanding, live
provider availability, statistical model reliability, or production explanation UX.

Known limitations: accepted closed packet-derived wording grammar intentionally
limits expression. LLM semantic reproducibility does not imply byte identity.
C10 makes no live model call and reads no provider secret.

Product Owner assessment: PENDING_PRODUCT_OWNER_DECISION.
Product Owner notes: PENDING_PRODUCT_OWNER_DECISION.

### A09 HUMAN_REVIEW_ERGONOMICS

Review question: Is the artifact-level review package usable for a Human ACCEPT /
REJECT / DEFER decision in OFFLINE / SHADOW / HUMAN-IN-THE-LOOP mode without
operational execution?

Technical status: EVIDENCE_READY.

Accepted evidence and concrete anchors:
`docs/w03/checkpoints/c06/W03_C06_HUMAN_DECISION_CONTRACT.md`;
`docs/w03/checkpoints/c06/W03_C06_APPEND_ONLY_STORE_CONTRACT.md`;
`tests/test_c06_human.py::test_canonical_event_construction_for_every_decision`;
`tests/test_c06_human.py::test_all_current_c05_dispositions_are_reviewable_without_execution`;
`tests/test_c06_store.py::test_three_event_chain_preserves_historical_bytes`;
`tests/test_c06_harness.py::test_journal_has_no_overwrite_or_delete_api`.
Critical regression: F06 HUMAN_AUTHORITY_AUDIT.

What evidence proves: DecisionPacket plus ExplanationRecord form an artifact-level
review surface. Explicit Human actor/time and ACCEPT/REJECT/DEFER are recorded as
immutable append-only HumanDecisionEvent history; later events retain prior bytes.
Every C05 v1 disposition is reviewable without executing it.

What evidence does NOT prove: production UI usability, a user study, an authenticated
production approval system, operational execution, or C10 business acceptance.

Known limitations: W3 v0 review is artifact-level. A Human ACCEPT event concerning
a packet is a review record, not the separate Product Owner C10 acceptance gate.

Product Owner assessment: PENDING_PRODUCT_OWNER_DECISION.
Product Owner notes: PENDING_PRODUCT_OWNER_DECISION.

### A10 REPLAYABILITY

Review question: Can an accepted decision run be reproduced and audited from frozen
identities while evaluation/HGT remains isolated and runtime behavior remains
deterministic-first?

Technical status: EVIDENCE_READY.

Accepted evidence and concrete anchors:
`docs/w03/checkpoints/c01/W03_C01_IDENTITY_PROVENANCE_SERIALIZATION.md`;
`docs/w03/checkpoints/c07/W03_C07_REPLAY_HARNESS_SPEC.md`;
`tests/test_c07_replay.py::test_r1_g1_g2_and_g6_packets_bind_to_actual_dataset_rows`;
`tests/test_c07_replay.py::test_same_process_replay_is_byte_identical_and_non_mutating`;
`tests/test_c07_harness.py::test_h31_fresh_runtime_imports_do_not_reach_evaluation_or_hgt`;
`tests/integration/test_decision_snapshot_database.py::test_read_only_replay_and_bounded_sql`;
C09 manifest and accepted exact-SHA chain in Section 1.
Critical regression: F07, F09 REAL_DATASET_BINDING_DIRECTION and F10.

What evidence proves: dataset version/hash, order/as_of_time, snapshot ID/hash,
artifact/provenance and policy/scenario/tool/code identities support deterministic
replay. Real generated business rows drive packets; protected evaluation does not
feed HGT, truth labels or scores into original recommendation/runtime. Canonical
payload comparison and capability traps detect mutation or forbidden access.

What evidence does NOT prove: identical live LLM wording, future production
availability, correctness outside frozen synthetic scenarios, or runtime use of HGT.

Known limitations: protected evaluation metrics are harness evidence, never runtime
reasoning input. Local proof without PostgreSQL/Compose is insufficient; exact-SHA
remote FULL proof is mandatory. OutcomeEvaluation is deferred under C07; a
HumanDecisionEvent is not an operational business outcome. Branch protection
remains unchanged/outside C10.

Product Owner assessment: PENDING_PRODUCT_OWNER_DECISION.
Product Owner notes: PENDING_PRODUCT_OWNER_DECISION.

## 4. W01-W06 representative walkthroughs

These are existing fixture/assertion walkthroughs, not newly executed business
runs or invented example outputs. They collectively cover the accepted chain;
they do not claim one newly integrated C10 orchestrator.

### W01 — State / Trust

Use `tests/test_decision_snapshot.py::make_run` and `sample_records`: order SO-1,
as_of_time 2026-01-20T00:00:00Z, fixture dataset dsv-1 with hash `"a" * 64`
(the test identity, not an external dataset hash). The source fixture contains
latest statuses and later completion/receipt dates. Snapshot exclusion assertions
remove status, future actual_end_at/completed_quantity/received_quantity.

Follow `tests/test_decision_evidence.py::test_association_derivation_and_quality_unknowns`:
admitted delivered quantity 4, remaining quantity 6, PARTIALLY_DELIVERED_AS_OF,
IN_PROGRESS_AS_OF, NOT_RECEIVED_AS_OF, unresolved failed quantity 2. PO evidence
remains associative with DOES_NOT_ESTABLISH_ORDER_SPECIFIC_ALLOCATION.
QUALITY_FINALITY_UNKNOWN and QUALITY_DISPOSITION_UNKNOWN remain explicit.
`test_source_evidence_is_exactly_snapshot_backed` checks provenance and available_at.
The separate `test_three_critical_conflicts_are_preserved` keeps all three conflict
codes critical and UNRESOLVED, with evidence references retained.
Dimensions A01/A03/A04; F01/F02. These assertions do not establish formal release.

### W02 — Risk / Diagnosis

Follow `tests/test_c03_signals.py::test_published_golden_signal_vectors` and the
published `docs/w03/checkpoints/c03/specs/acceptance_vectors.json`; C03-G32 rejects
a critical conflict with C03_CRITICAL_CONFLICT / BLOCKED_TRUST.
`tests/test_c03_diagnosis.py::test_diagnosis_is_fixed_template_structured_and_noncausal`
asserts OBSERVED_DELIVERY_RISK_INDICATORS for SO-1, C03_STRUCTURED_NOT_CAUSAL,
exact claim-to-signal evidence IDs/limitations, and visible QUALITY_FINALITY_UNKNOWN.
Active/unknown claims follow fixed policy text; inactive claims are omitted.
Dimensions A02/A03/A04; F03, with actual dataset direction proof F09.
No source claim is promoted to causal/root-cause truth.

### W03 — Intervention / Counterfactual

Read C04 registry/mapping and `specs/registry_policy.json`: exactly the four
families in A05; NO_ACTION is baseline identity, others are frozen stress mappings.
Follow `tests/test_c04_simulation.py::test_no_action_is_neutral_stable_and_has_exact_raw_measurement_schema`:
without an active baseline, NO_ACTION succeeds with no scenario identity/affected
entities, while active families are UNAVAILABLE with C04_SIMULATION_BASELINE_NOT_SUPPLIED.
This is an unavailable path, not an invented successful active simulation.

For accepted supplied-baseline isolation, F04 includes the fresh-process adapter
execution and all three mutation/error cases in
`test_baseline_mutation_on_every_error_path_is_a_hard_fail`: mutation raises
C04_BASELINE_MUTATION / BLOCKED_INTEGRITY. C07 `test_required_replay_matrix`
separates observable, non-observable and neutral effects.
Dimensions A05/A06/A10; F04/F07. Modeled stress effects are not operational efficacy
or delivery guarantees; neither baseline nor operational truth may be changed.

### W04 — Recommendation / Abstention

Follow `tests/test_c05_policy.py::test_multi_active_matrix_preserves_unique_focus_ties_partial_and_nonmonotonic`
using the accepted C03-G27 fixture. A supplied worsening Supplier stress result
versus unchanged Quality yields INVESTIGATION_ONLY with the Supplier candidate.
Equal worsening yields DEFER_TO_HUMAN, no selected candidate and top_tie_count 2;
partial active comparison and nonmonotonic improvement also defer.
These test-supplied comparison results are synthetic policy vectors, not observed
intervention effects.

`test_delivery_unknown_and_all_active_unavailable_abstain` asserts
NO_RECOMMENDATION, including C05_ACTIVE_SIMULATION_EVIDENCE_UNAVAILABLE.
`test_strict_neutral_allows_capacity_unknown_only_and_selects_no_action` preserves
the accepted neutral NO_ACTION path without resolving CAPACITY_PRESSURE.
Recommendation/packet contracts freeze reasons, uncertainties and limitations
before explanation. Dimensions A04/A07/A05; F05. No execution authority follows.

### W05 — Explanation / Human Review

Follow `tests/test_c08_template.py::test_template_preserves_frozen_meaning_and_boundary`:
the same packet yields ordered sections preserving disposition, selected candidate,
allowed evidence IDs and every uncertainty/limitation, ending with the Human boundary.
F08 injection and grounding tests reject unsupported prose without schema repair.
`tests/test_c08_explanation.py::test_second_schema_failure_degrades_after_exactly_two_calls`
uses FakeProvider and visibly yields DEGRADED_TEMPLATE with C08_EXPLANATION_DEGRADED;
packet-only fallback preserves recommendation. No live call is needed.

Then follow the F06 canonical event test for each ACCEPT/REJECT/DEFER and
`test_all_current_c05_dispositions_are_reviewable_without_execution`.
The append-only store's three-event chain preserves history; no overwrite/delete
API exists. Dimensions A08/A09/A04; F06/F08/F10.
These HumanDecisionEvent tests do not constitute Product Owner C10 acceptance
and do not claim a production UI or authorize SO/WO/PO/Delivery mutation.

### W06 — Replay / Protection

Follow C07 `test_r1_g1_g2_and_g6_packets_bind_to_actual_dataset_rows`:
packet dataset version/hash and every source value bind to actual generated rows.
`test_same_process_replay_is_byte_identical_and_non_mutating` preserves packet and
dataset bytes across evaluation. F07 cross-process replay/protected import tests,
F09 read-only PostgreSQL replay/bounded SQL and F10 capability isolation collectively
prove the accepted protected boundaries.

In `test_required_replay_matrix`, arrival-only capacity effects are explicitly
non-observable (evaluation.applicable false, cause-direction null); neutral control
requires neutral stability true and false-positive false. CAPACITY_PRESSURE remains
UNKNOWN. These are frozen harness expectations, not published HGT truth payloads.
Evaluation stays separate with no feedback into the original recommendation.
Dimensions A10/A06/A03/A04; F07/F09/F10. No protected dataset or live operational
data is extracted into this dossier.

## 5. W3 exit criteria

| Exit criterion | Accepted evidence anchors | C10 dimensions |
|---|---|---|
| OBSERVE | C02 snapshot matrix; W01 snapshot/time assertions; F01/F02 | A01 |
| TRUST | C02 evidence/context partition, provenance, conflicts; W01; F02 | A01, A03, A04 |
| DETECT | C03 rulebook/golden signal vectors; W02; F03/F09 | A02 |
| DIAGNOSE | C03 diagnosis contract and fixed noncausal claim/evidence assertions; W02; F03 | A02, A03 |
| SIMULATE | C04 registry/simulation isolation and neutral controls; W03; F04 | A05, A06 |
| RECOMMEND | C05 frozen recommendation/packet, tie/abstention matrix; W04; F05 | A07, A04 |
| EXPLAIN | C08 packet-derived grammar, grounding/degradation/template; W05; F08 | A08, A04 |
| REVIEW | C06 ACCEPT/REJECT/DEFER and append-only record, no execution; W05; F06 | A09 |
| EVALUATE | C07 protected replay matrix/non-observable effects; W03/W06; F07 | A06, A10 |
| REPRODUCE | C01 identity/serialization, C07 row binding/replay, C09 exact-SHA gate; W06; F07/F09 | A10 |
| PROTECT | temporal/association/UNKNOWN, no HGT/mutation/unauthorized capability; W01-W06; F02/F04/F08/F10 | A03, A04, A08, A10 |

All 11 exit verbs are represented. Coverage is technical evidence for Human review,
not an automated business exit decision.

## 6. Explicit non-capabilities

No operational execution; no autonomous scheduling, procurement, supplier replacement
or quality release; no production deployment; no ERP/MES integration; no free-form
LLM tool use; no runtime HGT; no automatic business acceptance; no production UI claim.
No new runtime/candidate/signal/decision policy, numeric business threshold/weight,
dependency, schema, migration, API, worker, provider/model/prompt or capability is
added by C10. C01-C09 and W1/W2 semantics are inherited unchanged.

## 7. Known limitations

- Synthetic/industry-inspired fixtures and bounded scenarios do not establish a
  real enterprise result. UNKNOWN, missing evidence and unresolved conflict are valid.
- W2 status history is not bitemporal; procurement allocation is associative;
  rework does not establish formal release; inventory freshness is synthetic.
- C04 families are dataset-scoped stress probes, not remedy efficacy. C05 categorical
  investigation focus/ties/abstention are not calibrated prediction or optimization.
- C07 capacity arrival-only observability and CAPACITY_PRESSURE UNKNOWN remain visible.
  Protected evaluation scores never enter original runtime recommendation.
  OutcomeEvaluation is deferred; HumanDecisionEvent records are not business outcomes.
- C08 accepted closed packet-derived explanation grammar is intentionally constrained;
  live LLM wording is semantically bounded, not byte-deterministic.
- Existing Starlette/httpx deprecation warning remains; dependency changes are outside
  scope. C09 report Section 20 records this accepted limitation.
- Branch protection is unchanged/outside C10 scope. Required remote exact-SHA proof
  does not grant PR merge permission. Artifact review does not claim production UX.

Codex does not decide whether these limitations are acceptable to the Product Owner.

## 8. Technical readiness conclusion

A01-A10: 10 / 10 EVIDENCE_READY from accepted repository evidence.

The final TECHNICAL ACCEPTANCE READINESS result is deferred to the mandatory
post-CI H01-H34 audit and separate readiness report. It may become PASS only after
the actual C10 C / FULL_EXACT_SHA CI passes all required jobs and the audit is
34/34 PASS. This dossier does not pre-claim that future result.

BUSINESS ACCEPTANCE: PENDING PRODUCT OWNER DECISION.
HUMAN C10 ACCEPTANCE: PENDING.
C10 CLOSED: NO. W03 SPRINT CLOSED: NO. PR #6 MERGE AUTHORIZED: NO.

## 9. Product Owner worksheet

| ID | Dimension | Product Owner assessment | Product Owner notes |
|---|---|---|---|
| A01 | STATE_INTERPRETABILITY | PENDING_PRODUCT_OWNER_DECISION | PENDING_PRODUCT_OWNER_DECISION |
| A02 | RISK_USEFULNESS | PENDING_PRODUCT_OWNER_DECISION | PENDING_PRODUCT_OWNER_DECISION |
| A03 | EVIDENCE_USEFULNESS | PENDING_PRODUCT_OWNER_DECISION | PENDING_PRODUCT_OWNER_DECISION |
| A04 | HONESTY_OF_UNCERTAINTY | PENDING_PRODUCT_OWNER_DECISION | PENDING_PRODUCT_OWNER_DECISION |
| A05 | INTERVENTION_USEFULNESS | PENDING_PRODUCT_OWNER_DECISION | PENDING_PRODUCT_OWNER_DECISION |
| A06 | COUNTERFACTUAL_CLARITY | PENDING_PRODUCT_OWNER_DECISION | PENDING_PRODUCT_OWNER_DECISION |
| A07 | RECOMMENDATION_USEFULNESS | PENDING_PRODUCT_OWNER_DECISION | PENDING_PRODUCT_OWNER_DECISION |
| A08 | EXPLANATION_FAITHFULNESS | PENDING_PRODUCT_OWNER_DECISION | PENDING_PRODUCT_OWNER_DECISION |
| A09 | HUMAN_REVIEW_ERGONOMICS | PENDING_PRODUCT_OWNER_DECISION | PENDING_PRODUCT_OWNER_DECISION |
| A10 | REPLAYABILITY | PENDING_PRODUCT_OWNER_DECISION | PENDING_PRODUCT_OWNER_DECISION |

The separately supplied `W03_C10_HUMAN_ACCEPTANCE_FORM.md` remains uncompleted.

## 10. Next gate

GPT W03-C10 INDEPENDENT ACCEPTANCE-READINESS REVIEW.

Independent GPT review is PENDING. Human acceptance, C10/W3 closeout, PR merge,
draft-to-ready, auto-merge enablement and post-W3 work are not authorized.
